|
Market Closed -
OTC Markets
15:59:59 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 15.04 USD | +0.53% |
|
+3.44% | +13.17% |
| 08-17 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
Chart calendar Astellas Pharma Inc.
Upcoming events on Astellas Pharma Inc.
| 2026-09-29 | Ex-dividend date - 40 JPY | 00:00 |
Past events on Astellas Pharma Inc.
| 2026-08-05 | Earnings release - Q1 2027 | 02:30 |
| 2026-08-05 | Earnings presentation | 03:00 |
| 2026-06-18 | Annual General Meeting | |
| 2026-06-18 | Présentation aux Actionnaires / Analystes | 21:00 |
| 2026-06-03 | Analyst/Investor Day | 08:10 |
| 2026-05-26 | Information meeting | 03:00 |
| 2026-05-14 | Board of Directors Meeting | |
| 2026-04-27 | Earnings release - Annual 2026 | 02:30 |
| 2026-04-27 | Earnings presentation | 03:00 |
| 2026-04-26 | Board of Directors Meeting | |
| 2026-03-30 | Information meeting | 20:01 |
| 2026-02-25 | Analyst/Investor Day | 20:00 |
| 2026-02-04 | Earnings presentation | 02:00 |
| 2026-02-04 | Earnings release - Q3 2026 | 01:30 |
| 2025-12-08 | Information meeting | 19:01 |
| 2025-10-30 | Earnings presentation | 03:15 |
| 2025-10-30 | Earnings release - Q2 2026 | 02:30 |
| 2025-10-23 | Information meeting | 20:01 |
Past dividends on Astellas Pharma Inc.
| 2026-03-30 | Ex-dividend date - 39 JPY | 00:00 |
| 2025-09-29 | Ex-dividend date - 39 JPY | 00:00 |
Annual results
| Fiscal Period | March | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 603 672 1 571 972 2.02% | 1 912 323 1 879 783 1.73% | 2 139 245 2 132 090 0.34% | 2 315 496 | 2 136 534 | 1 896 709 |
|
EBITDA Million JPY | Released Forecast Spread | 183 358 264 920 -30.79% | 240 171 382 224 -37.16% | 577 227 606 543 -4.83% | 716 076 | 662 456 | 558 086 |
|
EBIT Million JPY | Released Forecast Spread | 25 518 89 542 -71.5% | 41 039 49 953 -17.84% | 382 633 408 040 -6.23% | 484 244 | 452 097 | 367 633 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 24 969 24 853 0.47% | 31 237 27 715 12.71% | 376 587 374 105 0.66% | 460 119 | 434 604 | 326 249 |
|
Net income Million JPY | Released Forecast Spread | 17 045 13 409 27.12% | 50 747 26 466 91.74% | 291 535 296 438 -1.65% | 355 833 | 332 560 | 252 140 |
|
EPS JPY | Released Forecast Spread | 9,51 13,2 -28.05% | 28,4 15,9 78.26% | 163 171 -4.77% | 206 | 194 | 151 |
| Announcement Date | 25/04/24 | 25/04/25 | 27/04/26 | - |
Quarterly results
| Fiscal Period | March | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 S1 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 462 497 425 282 8.75% | 935 621 916 183 2.12% | 517 408 433 900 19.25% | 459 294 448 340 2.44% | 505 794 466 640 8.39% | 524 320 480 396 9.14% | 1 030 114 945 286 8.97% | 571 206 532 886 7.19% | 537 925 516 347 4.18% | 640 914 561 608 14.12% | 579 342 | 1 143 073 | 616 941 | 531 720 |
|
EBITDA Million JPY | Released Forecast Spread | 93 070 59 074 57.55% | -65 027 84 050 -177.37% | 111 203 76 300 45.74% | 142 451 107 950 31.96% | 152 025 128 850 17.99% | 183 638 139 900 31.26% | 99 163 120 397 -17.64% | 234 394 181 450 29.18% | 185 550 | 195 450 | 112 350 | |||
|
EBIT Million JPY | Released Forecast Spread | 43 053 52 879 -18.58% | 93 710 128 279 -26.95% | -116 191 43 250 -368.65% | 63 520 23 452 170.85% | 94 647 41 262 129.38% | 104 731 68 833 52.15% | 199 378 60 979 226.96% | 134 502 107 511 25.11% | 48 803 62 750 -22.23% | 184 506 135 080 36.59% | 146 065 | 258 243 | 127 500 | 42 750 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 38 547 57 286 -32.71% | 89 042 124 879 -28.7% | -118 359 77 375 -252.97% | 60 554 59 417 1.91% | 90 416 35 332 155.9% | 104 190 60 848 71.23% | 194 606 55 979 247.64% | 133 957 102 166 31.12% | 48 024 81 000 -40.71% | 186 514 123 400 51.15% | 148 000 | 253 243 | 129 800 | 35 900 |
|
Net income Million JPY | Released Forecast Spread | 35 908 41 367 -13.2% | 73 511 93 206 -21.13% | -97 660 54 894 -277.91% | 74 896 46 749 60.21% | 68 422 27 527 148.56% | 79 213 46 074 71.93% | 147 635 48 701 203.15% | 100 379 78 412 28.01% | 43 521 64 329 -32.35% | 141 828 106 592 33.06% | 114 814 | 192 465 | 109 077 | 26 315 |
|
EPS JPY | Released Forecast Spread | 20,1 16,0 25.65% | 41,1 39,4 4.21% | -54,6 8,07 -776.31% | 41,8 4,30 873.37% | 38,2 18,1 111.21% | 44,2 28,9 53.25% | 82,4 27,2 203.09% | 56,0 42,4 32.03% | 24,3 21,4 13.31% | 79,2 51,0 55.32% | 59,4 | 108 | 60,5 | 14,5 |
| Announcement Date | 30/10/24 | 30/10/24 | 04/02/25 | 25/04/25 | 30/07/25 | 30/10/25 | 30/10/25 | 04/02/26 | 27/04/26 | 05/08/26 | - | - | - | - |
| Today |  | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 |
Past sector events for Astellas Pharma Inc.
| 2026-08-21 | | Ex-dividend date - 2.52 USD | 00:00 |
| 2026-08-21 | | Ex-dividend date - 0.12 USD | 00:00 |
| 2026-08-21 | | Earnings presentation | 04:00 |
| 2026-08-21 | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| 2026-08-21 | | Earnings presentation | 08:00 |
| 2026-08-21 | | Earnings release - Q2 2026 | |
| 2026-08-21 | | Earnings release - Q2 2026 | |
| 2026-08-21 | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Calendar Astellas Pharma Inc.
Select your edition
All financial news and data tailored to specific country editions
